Atlas Trials

Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects

Clinical trial NCT00701363 · COMPLETED

Trial details

NCT number
NCT00701363
Sponsor
Ipsen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Acromegaly
Start date
2008-10-01
Primary completion
2013-03-01
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.